GlassScriptPhysician profile
Min P Kim
NPI 1558689661
$184,590.01
in general payments reported to CMS, 2019-2025
16 companies · $23K in 2025
The $23K reported for 2025 was more than what 94% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20K · 2020: $34K · 2021: $28K · 2022: $29K · 2023: $20K · 2024: $29K · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $63K · Travel and Lodging: $5,085 · Food and Beverage: $2,518 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $62,951.40 |
| Travel and Lodging | $5,085.26 |
| Food and Beverage | $2,517.77 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $115,212.31 | 2019-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Veran Medical Technologies, INC. | $33,951.82 | 2019-2021 | |
| Medtronic, INC. | $20,920.47 | 2021-2025 | Endoflip, Signia |
| Covidien LP | $8,934.40 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $1,565.08 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $1,074.00 | 2021 | |
| Ethicon INC. | $1,006.56 | 2019-2020 | |
| Medical Device Business Services, INC. | $732.38 | 2020 | |
| Atricure, INC. | $440.19 | 2019-2025 | Atricure Cryoice Cryosphere Cryoablation System, Atriclip Laa Exclusion System |
| Medela LLC | $316.50 | 2024 | Art. 101030215 Thopaz+ Chest Drainage, Dominant Flex |
| Depuy Synthes Sales INC. | $150.00 | 2024 | Matrixcombo |
| Ethicon US, LLC | $149.70 | 2019-2025 | Echelon Endopath |
| Olympus America INC. | $77.66 | 2021-2022 | |
| Kls-Martin L.P. | $24.21 | 2021 | |
| Tela Bio, INC. | $19.57 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumendi LLC | $15.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Min Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.